カテゴリ： 世界, 医療/バイオ, QYResearch

血漿分画技術の世界市場2023年：アルブミン、免疫グロブリン、凝固因子、その他

■ 英語タイトル：Global Blood Plasma Fractionation Technology Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7431）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7431
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：98
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[血漿分画技術の世界市場2023年：アルブミン、免疫グロブリン、凝固因子、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は血漿分画技術のグローバル市場について調査・分析し、世界の血漿分画技術市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（アルブミン、免疫グロブリン、凝固因子、その他）、用途別セグメント分析（病院、薬局、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Takeda、CSL、Grifols、Octapharma、Kedrion、LFB Group、Biotest、BPL、RAAS、CBPO、Hualan Bio、Tiantan Bio、Shuanglin Bio、Boya Bio、Yuanda Shuyang、Weiguang Bio、Nanyue Bio、KM Biologicsなどが含まれています。血漿分画技術のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、血漿分画技術市場規模を算出する際に考慮しました。

・血漿分画技術市場の概要
- 血漿分画技術の種類別セグメント
- 世界の血漿分画技術市場規模：タイプ別分析（アルブミン、免疫グロブリン、凝固因子、その他）
- 血漿分画技術の用途別セグメント
- 世界の血漿分画技術市場規模：用途別分析（病院、薬局、その他）
- 世界の血漿分画技術市場規模予測（2018年-2029年）

・血漿分画技術市場の成長トレンド
- 血漿分画技術の地域別市場規模（2018年-2029年）
- 血漿分画技術市場ダイナミクス
- 血漿分画技術の業界動向
- 血漿分画技術市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：アルブミン、免疫グロブリン、凝固因子、その他
- 世界の血漿分画技術のタイプ別市場規模（2018年-2023年）
- 世界の血漿分画技術のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、薬局、その他
- 世界の血漿分画技術の用途別市場規模（2018年-2023年）
- 世界の血漿分画技術の用途別市場規模（2024年-2029年）

・血漿分画技術の地域別市場規模
- 北米の血漿分画技術市場規模（2018年-2029年）
- 米国の血漿分画技術市場規模（2018年-2029年）
- ヨーロッパの血漿分画技術市場規模（2018年-2029年）
- アジア太平洋の血漿分画技術市場規模（2018年-2029年）
- 中国の血漿分画技術市場規模（2018年-2029年）
- 日本の血漿分画技術市場規模（2018年-2029年）
- 韓国の血漿分画技術市場規模（2018年-2029年）
- インドの血漿分画技術市場規模（2018年-2029年）
- オーストラリアの血漿分画技術市場規模（2018年-2029年）
- 中南米の血漿分画技術市場規模（2018年-2029年）
- 中東・アフリカの血漿分画技術市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Takeda、CSL、Grifols、Octapharma、Kedrion、LFB Group、Biotest、BPL、RAAS、CBPO、Hualan Bio、Tiantan Bio、Shuanglin Bio、Boya Bio、Yuanda Shuyang、Weiguang Bio、Nanyue Bio、KM Biologics

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Blood Plasma Fractionation Technology market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Blood Plasma Fractionation Technology is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Blood Plasma Fractionation Technology is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Blood Plasma Fractionation Technology in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Blood Plasma Fractionation Technology include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Blood Plasma Fractionation Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Plasma Fractionation Technology.
The Blood Plasma Fractionation Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Blood Plasma Fractionation Technology market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Plasma Fractionation Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
Segment by Type
Albumin
Immune Globulin
Coagulation Factor
Others
Segment by Application
Hospital
Retail Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Plasma Fractionation Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Plasma Fractionation Technology Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Albumin
1.2.3 Immune Globulin
1.2.4 Coagulation Factor
1.2.5 Others
1.3 Market by Application
1.3.1 Global Blood Plasma Fractionation Technology Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Plasma Fractionation Technology Market Perspective (2018-2029)
2.2 Blood Plasma Fractionation Technology Growth Trends by Region
2.2.1 Global Blood Plasma Fractionation Technology Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Blood Plasma Fractionation Technology Historic Market Size by Region (2018-2023)
2.2.3 Blood Plasma Fractionation Technology Forecasted Market Size by Region (2024-2029)
2.3 Blood Plasma Fractionation Technology Market Dynamics
2.3.1 Blood Plasma Fractionation Technology Industry Trends
2.3.2 Blood Plasma Fractionation Technology Market Drivers
2.3.3 Blood Plasma Fractionation Technology Market Challenges
2.3.4 Blood Plasma Fractionation Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Plasma Fractionation Technology Players by Revenue
3.1.1 Global Top Blood Plasma Fractionation Technology Players by Revenue (2018-2023)
3.1.2 Global Blood Plasma Fractionation Technology Revenue Market Share by Players (2018-2023)
3.2 Global Blood Plasma Fractionation Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blood Plasma Fractionation Technology Revenue
3.4 Global Blood Plasma Fractionation Technology Market Concentration Ratio
3.4.1 Global Blood Plasma Fractionation Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Plasma Fractionation Technology Revenue in 2022
3.5 Blood Plasma Fractionation Technology Key Players Head office and Area Served
3.6 Key Players Blood Plasma Fractionation Technology Product Solution and Service
3.7 Date of Enter into Blood Plasma Fractionation Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Plasma Fractionation Technology Breakdown Data by Type
4.1 Global Blood Plasma Fractionation Technology Historic Market Size by Type (2018-2023)
4.2 Global Blood Plasma Fractionation Technology Forecasted Market Size by Type (2024-2029)
5 Blood Plasma Fractionation Technology Breakdown Data by Application
5.1 Global Blood Plasma Fractionation Technology Historic Market Size by Application (2018-2023)
5.2 Global Blood Plasma Fractionation Technology Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Blood Plasma Fractionation Technology Market Size (2018-2029)
6.2 North America Blood Plasma Fractionation Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Blood Plasma Fractionation Technology Market Size by Country (2018-2023)
6.4 North America Blood Plasma Fractionation Technology Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Plasma Fractionation Technology Market Size (2018-2029)
7.2 Europe Blood Plasma Fractionation Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Blood Plasma Fractionation Technology Market Size by Country (2018-2023)
7.4 Europe Blood Plasma Fractionation Technology Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Plasma Fractionation Technology Market Size (2018-2029)
8.2 Asia-Pacific Blood Plasma Fractionation Technology Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Blood Plasma Fractionation Technology Market Size by Region (2018-2023)
8.4 Asia-Pacific Blood Plasma Fractionation Technology Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Plasma Fractionation Technology Market Size (2018-2029)
9.2 Latin America Blood Plasma Fractionation Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Blood Plasma Fractionation Technology Market Size by Country (2018-2023)
9.4 Latin America Blood Plasma Fractionation Technology Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Plasma Fractionation Technology Market Size (2018-2029)
10.2 Middle East & Africa Blood Plasma Fractionation Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Blood Plasma Fractionation Technology Market Size by Country (2018-2023)
10.4 Middle East & Africa Blood Plasma Fractionation Technology Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Detail
11.1.2 Takeda Business Overview
11.1.3 Takeda Blood Plasma Fractionation Technology Introduction
11.1.4 Takeda Revenue in Blood Plasma Fractionation Technology Business (2018-2023)
11.1.5 Takeda Recent Development
11.2 CSL
11.2.1 CSL Company Detail
11.2.2 CSL Business Overview
11.2.3 CSL Blood Plasma Fractionation Technology Introduction
11.2.4 CSL Revenue in Blood Plasma Fractionation Technology Business (2018-2023)
11.2.5 CSL Recent Development
11.3 Grifols
11.3.1 Grifols Company Detail
11.3.2 Grifols Business Overview
11.3.3 Grifols Blood Plasma Fractionation Technology Introduction
11.3.4 Grifols Revenue in Blood Plasma Fractionation Technology Business (2018-2023)
11.3.5 Grifols Recent Development
11.4 Octapharma
11.4.1 Octapharma Company Detail
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Blood Plasma Fractionation Technology Introduction
11.4.4 Octapharma Revenue in Blood Plasma Fractionation Technology Business (2018-2023)
11.4.5 Octapharma Recent Development
11.5 Kedrion
11.5.1 Kedrion Company Detail
11.5.2 Kedrion Business Overview
11.5.3 Kedrion Blood Plasma Fractionation Technology Introduction
11.5.4 Kedrion Revenue in Blood Plasma Fractionation Technology Business (2018-2023)
11.5.5 Kedrion Recent Development
11.6 LFB Group
11.6.1 LFB Group Company Detail
11.6.2 LFB Group Business Overview
11.6.3 LFB Group Blood Plasma Fractionation Technology Introduction
11.6.4 LFB Group Revenue in Blood Plasma Fractionation Technology Business (2018-2023)
11.6.5 LFB Group Recent Development
11.7 Biotest
11.7.1 Biotest Company Detail
11.7.2 Biotest Business Overview
11.7.3 Biotest Blood Plasma Fractionation Technology Introduction
11.7.4 Biotest Revenue in Blood Plasma Fractionation Technology Business (2018-2023)
11.7.5 Biotest Recent Development
11.8 BPL
11.8.1 BPL Company Detail
11.8.2 BPL Business Overview
11.8.3 BPL Blood Plasma Fractionation Technology Introduction
11.8.4 BPL Revenue in Blood Plasma Fractionation Technology Business (2018-2023)
11.8.5 BPL Recent Development
11.9 RAAS
11.9.1 RAAS Company Detail
11.9.2 RAAS Business Overview
11.9.3 RAAS Blood Plasma Fractionation Technology Introduction
11.9.4 RAAS Revenue in Blood Plasma Fractionation Technology Business (2018-2023)
11.9.5 RAAS Recent Development
11.10 CBPO
11.10.1 CBPO Company Detail
11.10.2 CBPO Business Overview
11.10.3 CBPO Blood Plasma Fractionation Technology Introduction
11.10.4 CBPO Revenue in Blood Plasma Fractionation Technology Business (2018-2023)
11.10.5 CBPO Recent Development
11.11 Hualan Bio
11.11.1 Hualan Bio Company Detail
11.11.2 Hualan Bio Business Overview
11.11.3 Hualan Bio Blood Plasma Fractionation Technology Introduction
11.11.4 Hualan Bio Revenue in Blood Plasma Fractionation Technology Business (2018-2023)
11.11.5 Hualan Bio Recent Development
11.12 Tiantan Bio
11.12.1 Tiantan Bio Company Detail
11.12.2 Tiantan Bio Business Overview
11.12.3 Tiantan Bio Blood Plasma Fractionation Technology Introduction
11.12.4 Tiantan Bio Revenue in Blood Plasma Fractionation Technology Business (2018-2023)
11.12.5 Tiantan Bio Recent Development
11.13 Shuanglin Bio
11.13.1 Shuanglin Bio Company Detail
11.13.2 Shuanglin Bio Business Overview
11.13.3 Shuanglin Bio Blood Plasma Fractionation Technology Introduction
11.13.4 Shuanglin Bio Revenue in Blood Plasma Fractionation Technology Business (2018-2023)
11.13.5 Shuanglin Bio Recent Development
11.14 Boya Bio
11.14.1 Boya Bio Company Detail
11.14.2 Boya Bio Business Overview
11.14.3 Boya Bio Blood Plasma Fractionation Technology Introduction
11.14.4 Boya Bio Revenue in Blood Plasma Fractionation Technology Business (2018-2023)
11.14.5 Boya Bio Recent Development
11.15 Yuanda Shuyang
11.15.1 Yuanda Shuyang Company Detail
11.15.2 Yuanda Shuyang Business Overview
11.15.3 Yuanda Shuyang Blood Plasma Fractionation Technology Introduction
11.15.4 Yuanda Shuyang Revenue in Blood Plasma Fractionation Technology Business (2018-2023)
11.15.5 Yuanda Shuyang Recent Development
11.16 Weiguang Bio
11.16.1 Weiguang Bio Company Detail
11.16.2 Weiguang Bio Business Overview
11.16.3 Weiguang Bio Blood Plasma Fractionation Technology Introduction
11.16.4 Weiguang Bio Revenue in Blood Plasma Fractionation Technology Business (2018-2023)
11.16.5 Weiguang Bio Recent Development
11.17 Nanyue Bio
11.17.1 Nanyue Bio Company Detail
11.17.2 Nanyue Bio Business Overview
11.17.3 Nanyue Bio Blood Plasma Fractionation Technology Introduction
11.17.4 Nanyue Bio Revenue in Blood Plasma Fractionation Technology Business (2018-2023)
11.17.5 Nanyue Bio Recent Development
11.18 KM Biologics
11.18.1 KM Biologics Company Detail
11.18.2 KM Biologics Business Overview
11.18.3 KM Biologics Blood Plasma Fractionation Technology Introduction
11.18.4 KM Biologics Revenue in Blood Plasma Fractionation Technology Business (2018-2023)
11.18.5 KM Biologics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Blood Plasma Fractionation Technology Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Albumin
Table 3. Key Players of Immune Globulin
Table 4. Key Players of Coagulation Factor
Table 5. Key Players of Others
Table 6. Global Blood Plasma Fractionation Technology Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Blood Plasma Fractionation Technology Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Blood Plasma Fractionation Technology Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Blood Plasma Fractionation Technology Market Share by Region (2018-2023)
Table 10. Global Blood Plasma Fractionation Technology Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Blood Plasma Fractionation Technology Market Share by Region (2024-2029)
Table 12. Blood Plasma Fractionation Technology Market Trends
Table 13. Blood Plasma Fractionation Technology Market Drivers
Table 14. Blood Plasma Fractionation Technology Market Challenges
Table 15. Blood Plasma Fractionation Technology Market Restraints
Table 16. Global Blood Plasma Fractionation Technology Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Blood Plasma Fractionation Technology Market Share by Players (2018-2023)
Table 18. Global Top Blood Plasma Fractionation Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Fractionation Technology as of 2022)
Table 19. Ranking of Global Top Blood Plasma Fractionation Technology Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Blood Plasma Fractionation Technology Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Blood Plasma Fractionation Technology Product Solution and Service
Table 23. Date of Enter into Blood Plasma Fractionation Technology Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Blood Plasma Fractionation Technology Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Blood Plasma Fractionation Technology Revenue Market Share by Type (2018-2023)
Table 27. Global Blood Plasma Fractionation Technology Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Blood Plasma Fractionation Technology Revenue Market Share by Type (2024-2029)
Table 29. Global Blood Plasma Fractionation Technology Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Blood Plasma Fractionation Technology Revenue Market Share by Application (2018-2023)
Table 31. Global Blood Plasma Fractionation Technology Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Blood Plasma Fractionation Technology Revenue Market Share by Application (2024-2029)
Table 33. North America Blood Plasma Fractionation Technology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Blood Plasma Fractionation Technology Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Blood Plasma Fractionation Technology Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Blood Plasma Fractionation Technology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Blood Plasma Fractionation Technology Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Blood Plasma Fractionation Technology Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Blood Plasma Fractionation Technology Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Blood Plasma Fractionation Technology Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Blood Plasma Fractionation Technology Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Blood Plasma Fractionation Technology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Blood Plasma Fractionation Technology Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Blood Plasma Fractionation Technology Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Blood Plasma Fractionation Technology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Blood Plasma Fractionation Technology Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Blood Plasma Fractionation Technology Market Size by Country (2024-2029) & (US$ Million)
Table 48. Takeda Company Detail
Table 49. Takeda Business Overview
Table 50. Takeda Blood Plasma Fractionation Technology Product
Table 51. Takeda Revenue in Blood Plasma Fractionation Technology Business (2018-2023) & (US$ Million)
Table 52. Takeda Recent Development
Table 53. CSL Company Detail
Table 54. CSL Business Overview
Table 55. CSL Blood Plasma Fractionation Technology Product
Table 56. CSL Revenue in Blood Plasma Fractionation Technology Business (2018-2023) & (US$ Million)
Table 57. CSL Recent Development
Table 58. Grifols Company Detail
Table 59. Grifols Business Overview
Table 60. Grifols Blood Plasma Fractionation Technology Product
Table 61. Grifols Revenue in Blood Plasma Fractionation Technology Business (2018-2023) & (US$ Million)
Table 62. Grifols Recent Development
Table 63. Octapharma Company Detail
Table 64. Octapharma Business Overview
Table 65. Octapharma Blood Plasma Fractionation Technology Product
Table 66. Octapharma Revenue in Blood Plasma Fractionation Technology Business (2018-2023) & (US$ Million)
Table 67. Octapharma Recent Development
Table 68. Kedrion Company Detail
Table 69. Kedrion Business Overview
Table 70. Kedrion Blood Plasma Fractionation Technology Product
Table 71. Kedrion Revenue in Blood Plasma Fractionation Technology Business (2018-2023) & (US$ Million)
Table 72. Kedrion Recent Development
Table 73. LFB Group Company Detail
Table 74. LFB Group Business Overview
Table 75. LFB Group Blood Plasma Fractionation Technology Product
Table 76. LFB Group Revenue in Blood Plasma Fractionation Technology Business (2018-2023) & (US$ Million)
Table 77. LFB Group Recent Development
Table 78. Biotest Company Detail
Table 79. Biotest Business Overview
Table 80. Biotest Blood Plasma Fractionation Technology Product
Table 81. Biotest Revenue in Blood Plasma Fractionation Technology Business (2018-2023) & (US$ Million)
Table 82. Biotest Recent Development
Table 83. BPL Company Detail
Table 84. BPL Business Overview
Table 85. BPL Blood Plasma Fractionation Technology Product
Table 86. BPL Revenue in Blood Plasma Fractionation Technology Business (2018-2023) & (US$ Million)
Table 87. BPL Recent Development
Table 88. RAAS Company Detail
Table 89. RAAS Business Overview
Table 90. RAAS Blood Plasma Fractionation Technology Product
Table 91. RAAS Revenue in Blood Plasma Fractionation Technology Business (2018-2023) & (US$ Million)
Table 92. RAAS Recent Development
Table 93. CBPO Company Detail
Table 94. CBPO Business Overview
Table 95. CBPO Blood Plasma Fractionation Technology Product
Table 96. CBPO Revenue in Blood Plasma Fractionation Technology Business (2018-2023) & (US$ Million)
Table 97. CBPO Recent Development
Table 98. Hualan Bio Company Detail
Table 99. Hualan Bio Business Overview
Table 100. Hualan Bio Blood Plasma Fractionation Technology Product
Table 101. Hualan Bio Revenue in Blood Plasma Fractionation Technology Business (2018-2023) & (US$ Million)
Table 102. Hualan Bio Recent Development
Table 103. Tiantan Bio Company Detail
Table 104. Tiantan Bio Business Overview
Table 105. Tiantan Bio Blood Plasma Fractionation Technology Product
Table 106. Tiantan Bio Revenue in Blood Plasma Fractionation Technology Business (2018-2023) & (US$ Million)
Table 107. Tiantan Bio Recent Development
Table 108. Shuanglin Bio Company Detail
Table 109. Shuanglin Bio Business Overview
Table 110. Shuanglin Bio Blood Plasma Fractionation Technology Product
Table 111. Shuanglin Bio Revenue in Blood Plasma Fractionation Technology Business (2018-2023) & (US$ Million)
Table 112. Shuanglin Bio Recent Development
Table 113. Boya Bio Company Detail
Table 114. Boya Bio Business Overview
Table 115. Boya Bio Blood Plasma Fractionation Technology Product
Table 116. Boya Bio Revenue in Blood Plasma Fractionation Technology Business (2018-2023) & (US$ Million)
Table 117. Boya Bio Recent Development
Table 118. Yuanda Shuyang Company Detail
Table 119. Yuanda Shuyang Business Overview
Table 120. Yuanda Shuyang Blood Plasma Fractionation Technology Product
Table 121. Yuanda Shuyang Revenue in Blood Plasma Fractionation Technology Business (2018-2023) & (US$ Million)
Table 122. Yuanda Shuyang Recent Development
Table 123. Weiguang Bio Company Detail
Table 124. Weiguang Bio Business Overview
Table 125. Weiguang Bio Blood Plasma Fractionation Technology Product
Table 126. Weiguang Bio Revenue in Blood Plasma Fractionation Technology Business (2018-2023) & (US$ Million)
Table 127. Weiguang Bio Recent Development
Table 128. Nanyue Bio Company Detail
Table 129. Nanyue Bio Business Overview
Table 130. Nanyue Bio Blood Plasma Fractionation Technology Product
Table 131. Nanyue Bio Revenue in Blood Plasma Fractionation Technology Business (2018-2023) & (US$ Million)
Table 132. Nanyue Bio Recent Development
Table 133. KM Biologics Company Detail
Table 134. KM Biologics Business Overview
Table 135. KM Biologics Blood Plasma Fractionation Technology Product
Table 136. KM Biologics Revenue in Blood Plasma Fractionation Technology Business (2018-2023) & (US$ Million)
Table 137. KM Biologics Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Blood Plasma Fractionation Technology Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Blood Plasma Fractionation Technology Market Share by Type: 2022 VS 2029
Figure 3. Albumin Features
Figure 4. Immune Globulin Features
Figure 5. Coagulation Factor Features
Figure 6. Others Features
Figure 7. Global Blood Plasma Fractionation Technology Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Blood Plasma Fractionation Technology Market Share by Application: 2022 VS 2029
Figure 9. Hospital Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Others Case Studies
Figure 12. Blood Plasma Fractionation Technology Report Years Considered
Figure 13. Global Blood Plasma Fractionation Technology Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Blood Plasma Fractionation Technology Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Blood Plasma Fractionation Technology Market Share by Region: 2022 VS 2029
Figure 16. Global Blood Plasma Fractionation Technology Market Share by Players in 2022
Figure 17. Global Top Blood Plasma Fractionation Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Fractionation Technology as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Blood Plasma Fractionation Technology Revenue in 2022
Figure 19. North America Blood Plasma Fractionation Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Blood Plasma Fractionation Technology Market Share by Country (2018-2029)
Figure 21. United States Blood Plasma Fractionation Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Blood Plasma Fractionation Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Blood Plasma Fractionation Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Blood Plasma Fractionation Technology Market Share by Country (2018-2029)
Figure 25. Germany Blood Plasma Fractionation Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Blood Plasma Fractionation Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Blood Plasma Fractionation Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Blood Plasma Fractionation Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Blood Plasma Fractionation Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Blood Plasma Fractionation Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Blood Plasma Fractionation Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Blood Plasma Fractionation Technology Market Share by Region (2018-2029)
Figure 33. China Blood Plasma Fractionation Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Blood Plasma Fractionation Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Blood Plasma Fractionation Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Blood Plasma Fractionation Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Blood Plasma Fractionation Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Blood Plasma Fractionation Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Blood Plasma Fractionation Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Blood Plasma Fractionation Technology Market Share by Country (2018-2029)
Figure 41. Mexico Blood Plasma Fractionation Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Blood Plasma Fractionation Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Blood Plasma Fractionation Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Blood Plasma Fractionation Technology Market Share by Country (2018-2029)
Figure 45. Turkey Blood Plasma Fractionation Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Blood Plasma Fractionation Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Takeda Revenue Growth Rate in Blood Plasma Fractionation Technology Business (2018-2023)
Figure 48. CSL Revenue Growth Rate in Blood Plasma Fractionation Technology Business (2018-2023)
Figure 49. Grifols Revenue Growth Rate in Blood Plasma Fractionation Technology Business (2018-2023)
Figure 50. Octapharma Revenue Growth Rate in Blood Plasma Fractionation Technology Business (2018-2023)
Figure 51. Kedrion Revenue Growth Rate in Blood Plasma Fractionation Technology Business (2018-2023)
Figure 52. LFB Group Revenue Growth Rate in Blood Plasma Fractionation Technology Business (2018-2023)
Figure 53. Biotest Revenue Growth Rate in Blood Plasma Fractionation Technology Business (2018-2023)
Figure 54. BPL Revenue Growth Rate in Blood Plasma Fractionation Technology Business (2018-2023)
Figure 55. RAAS Revenue Growth Rate in Blood Plasma Fractionation Technology Business (2018-2023)
Figure 56. CBPO Revenue Growth Rate in Blood Plasma Fractionation Technology Business (2018-2023)
Figure 57. Hualan Bio Revenue Growth Rate in Blood Plasma Fractionation Technology Business (2018-2023)
Figure 58. Tiantan Bio Revenue Growth Rate in Blood Plasma Fractionation Technology Business (2018-2023)
Figure 59. Shuanglin Bio Revenue Growth Rate in Blood Plasma Fractionation Technology Business (2018-2023)
Figure 60. Boya Bio Revenue Growth Rate in Blood Plasma Fractionation Technology Business (2018-2023)
Figure 61. Yuanda Shuyang Revenue Growth Rate in Blood Plasma Fractionation Technology Business (2018-2023)
Figure 62. Weiguang Bio Revenue Growth Rate in Blood Plasma Fractionation Technology Business (2018-2023)
Figure 63. Nanyue Bio Revenue Growth Rate in Blood Plasma Fractionation Technology Business (2018-2023)
Figure 64. KM Biologics Revenue Growth Rate in Blood Plasma Fractionation Technology Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 血漿分画の世界市場2023年：免疫グロブリン、凝固因子、アルブミン、その他
  • 血漿分画技術のグローバル市場展望 2023年-2029年：アルブミン、免疫グロブリン、凝固因子、その他
  • ヒト血漿分画のグローバル市場展望 2023年-2029年：免疫グロブリン、凝固因子、アルブミン、その他
  • 血漿タンパク質製品のグローバル市場展望 2023年-2029年：アルブミン、免疫グロブリン、凝固因子、その他
  • 血漿由来医療製品のグローバル市場展望 2023年-2029年：免疫グロブリン、凝固因子、アルブミン、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7431 )"血漿分画技術の世界市場2023年：アルブミン、免疫グロブリン、凝固因子、その他" (英文：Global Blood Plasma Fractionation Technology Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。